0001209191-23-024915.txt : 20230419 0001209191-23-024915.hdr.sgml : 20230419 20230419190653 ACCESSION NUMBER: 0001209191-23-024915 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230417 FILED AS OF DATE: 20230419 DATE AS OF CHANGE: 20230419 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Farrell Robert E Jr CENTRAL INDEX KEY: 0001592280 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38940 FILM NUMBER: 23831060 MAIL ADDRESS: STREET 1: CAMBRIDGE DISCOVERY PARK STREET 2: 100 ACORN PARK DRIVE, 5TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02140 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Morphic Holding, Inc. CENTRAL INDEX KEY: 0001679363 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 473878772 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 35 GATEHOUSE DRIVE A2 CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 9787296480 MAIL ADDRESS: STREET 1: 35 GATEHOUSE DRIVE A2 CITY: WALTHAM STATE: MA ZIP: 02451 FORMER COMPANY: FORMER CONFORMED NAME: Morphic Holding, LLC DATE OF NAME CHANGE: 20160712 4 1 doc4.xml FORM 4 SUBMISSION X0407 4 2023-04-17 0 0001679363 Morphic Holding, Inc. MORF 0001592280 Farrell Robert E Jr C/O MORPHIC HOLDING, INC. 35 GATEHOUSE DRIVE, A2 WALTHAM MA 02451 0 1 0 0 SVP Finance and CAO 1 Common Stock 2023-04-17 4 S 0 10000 40.00 D 12222 D Common Stock 2023-04-17 4 S 0 10000 42.5001 D 2222 D Common Stock 2023-04-19 4 M 0 10000 4.32 A 12222 D Stock Option (right to buy Common Stock) 4.32 2023-04-19 4 M 0 10000 0.00 D 2028-12-14 Common Stock 10000 50270 D The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.50 to $42.51 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The option is fully vested. /s/ Robert Farrell, Jr. 2023-04-19